For anyone who has avoided GLP-1 therapy specifically because of needles, this removes that obstacle entirely
For EDS specifically, data is still catching up, an issue compounded by the heterogeneity of EDS (what works for one subtype or individual may not for another)
5fi), which was associated with 4.9-fold decrease of nuclear MafA expression (Fig
Ozempic breath can be embarrassing for GLP-1 users but its turned out to be good news for confectioners
Recharge, Detox and Recover: How IV Therapy, Glutathione and Liver Support Can Optimize Your Health Life throws us many reasons to celebrate weddings, birthdays and spontaneous nights out with friends
Good point, but I'd push back on the framing before we get to care model - the data itself is a bit misleading